FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com


Join the forum, it's quick and easy

FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com
FINANCIAL CHRONICLE™
Would you like to react to this message? Create an account in a few clicks or log in to continue.
FINANCIAL CHRONICLE™

Encyclopedia of Latest news, reviews, discussions and analysis of stock market and investment opportunities in Sri Lanka

Click Link to get instant AI answers to all business queries.
Click Link to find latest Economic Outlook of Sri Lanka
Click Link to view latest Research and Analysis of the key Sectors and Industries of Sri Lanka
Worried about Paying Taxes? Click Link to find answers to all your Tax related matters
Do you have a legal issues? Find instant answers to all Sri Lanka Legal queries. Click Link
Latest images

Latest topics

» Sri Lanka: Stock Market Fraudsters with Criminal Prosecutions
by D.G.Dayaratne Today at 7:28 am

» hSenid Business Solutions(HBS)
by K.R Fri May 17, 2024 9:08 am

» CBSL Pension Fund vs EPF
by God Father Thu May 16, 2024 9:13 am

» EXPO.N - Expo Lanka Holdings De-Listing
by thankrishan Wed May 15, 2024 1:58 pm

» Nations Trust Bank: Consistent growth
by ErangaDS Wed May 15, 2024 8:46 am

» SOFTLOGIC LIFE INSURANCE PLC (AAIC.N0000)
by soileconomy Wed May 15, 2024 4:01 am

» Falsified accounts and financial misrepresentation at Arpico Insurance PLC (AINS)
by DeepFreakingValue Tue May 14, 2024 12:20 am

» Potential Super Gain with HSIG
by Investment 1st Mon May 13, 2024 12:20 am

» ජනාධිපතිවරණය - 2024
by ChooBoy Sat May 11, 2024 11:20 pm

» The IMF's Monumental Malpractices and future of Sri Lanka
by ChooBoy Sat May 11, 2024 11:18 pm

» Sri Lanka: Policy Challenge Addressing Poverty Vulnerability as the Economy Recovers
by ResearchMan Fri May 10, 2024 12:20 pm

» SINS - the Tailwind effects of a crisis hit Economy
by Equity Win Thu May 09, 2024 7:37 pm

» TAFL is the most undervalued & highly potential counter in the Poultry Sector
by atdeane Thu May 09, 2024 7:09 pm

» Sri Lanka: Country Information Report
by God Father Thu May 09, 2024 5:22 pm

» Sri Lanka polls could risk economic recovery
by God Father Thu May 09, 2024 5:12 pm

» AGSTAR PLC (AGST.N0000)
by ResearchMan Thu May 09, 2024 12:21 pm

» Browns becomes world’s biggest tea exporter in deal with LIPTON
by sureshot Wed May 08, 2024 9:51 pm

» Colombo Stock Market: Over Valued against USD!
by ResearchMan Wed May 08, 2024 12:49 pm

» COCR IN TROUBLE?
by D.G.Dayaratne Mon May 06, 2024 9:31 am

» Maharaja advise - April 2024
by celtic tiger Tue Apr 30, 2024 12:01 am

» Srilanka's Access Engineering PLC think and Win
by Dasun Maduwantha Mon Apr 29, 2024 11:40 pm

» PEOPLE'S INSURANCE PLC (PINS.N0000)
by ErangaDS Fri Apr 26, 2024 10:24 am

» UNION ASSURANCE PLC (UAL.N0000)
by ErangaDS Fri Apr 26, 2024 10:22 am

» ‘Port City Colombo makes progress in attracting key investments’
by samaritan Thu Apr 25, 2024 9:26 am

» Mahaweli Reach Hotels (MRH.N)
by SL-INVESTOR Wed Apr 24, 2024 11:25 pm

LISTED COMPANIES

Submit Post
ශ්‍රී ලංකා මූල්‍ය වංශකථාව - සිංහල
Submit Post


CONATCT US


Send your suggestions and comments

* - required fields

Read FINANCIAL CHRONICLE™ Disclaimer



EXPERT CHRONICLE™

ECONOMIC CHRONICLE

GROSS DOMESTIC PRODUCT (GDP)



CHRONICLE™ YouTube


You are not connected. Please login or register

COVID-19 Coronavirus Vaccine

Go down  Message [Page 1 of 1]

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

Health 09:35, 25-Oct-2020

[size=15]Translate



[size=36]Brazil institute to import 6 million doses of Chinese COVID-19 vaccine[/size]
Updated 16:01, 26-Oct-2020
CGTN[/size]
Share
COVID-19 Coronavirus Vaccine Facebook@3x[url=https://twitter.com/intent/tweet?text=Brazil institute to import 6 million doses of Chinese COVID-19 vaccine&url=https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html&via=cgtnofficial]COVID-19 Coronavirus Vaccine Twitter@3x[/url][url=http://service.weibo.com/share/share.php?appkey=4122844478&title=Brazil institute to import 6 million doses of Chinese COVID-19 vaccine&url=https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html&pic=&searchPic=true&style=simple]COVID-19 Coronavirus Vaccine Weibo@3x[/url]COVID-19 Coronavirus Vaccine Wechat@3x[email=?subject=Brazil%20institute%20to%20import%206%20million%20doses%20of%20Chinese%20COVID-19%20vaccine&body=I%20thought%20you%20might%20be%20interested%20in%20this%20news%3A%20https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html.]COVID-19 Coronavirus Vaccine Mail@3x[/email]COVID-19 Coronavirus Vaccine Copy@3x

COVID-19 Coronavirus Vaccine E1bd8f4f828441529527dd3b091b0fff

A worker performs quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, September 24, 2020. /Reuters
Brazilian health regulator Anvisa on Friday authorized a biomedical center to import six million doses of the Sinovac coronavirus vaccine, one day after President Jair Bolsonaro said Brazil would not buy the Chinese vaccine.
Sao Paulo's Butantan Institute plans to initially import Sinovac's vaccine, which is in the third phase of trials conducted with the help of a local university and not yet approved for wider use in Brazil. Butantan would ultimately manufacture the vaccine if proven effective.
Brazil's Sao Paulo Governor Joao Doria said earlier on Friday that Anvisa told him it will not bow to political pressure over the approval of potential coronavirus vaccines.
According to the Brazilian state governors, the country will include China's Sinovac vaccine against COVID-19 in its national immunization program.
Joao said after the health ministry meeting that the federal government has agreed to buy 46 million doses of the Sinovac vaccine.
The program could begin in January 2021, he said, which could make it one of the first immunization efforts against the novel coronavirus in the world.
Sao Paulo State Health Secretary Jean Gorinchteyn said the vaccine appeared to produce protective antibodies. The state hopes to obtain regulatory approval for CoronaVac by the end of the year to start inoculating its population early in 2021, in what could be the first vaccination programs in the Americas.
In addition, another Brazilian pharmaceutical company was reported on Friday to have already signed an agreement with the Russian Direct Investment Fund (RDIF) to produce Russia's Sputnik V vaccine against COVID-19 starting in the second half of November.
The company said it was bound by a confidentiality agreement not to give any technical or scientific details. It still must obtain approval from Anvisa.
With more than 5.3 million cases of coronavirus reported in Brazil, the third worst outbreak after the United States and India, the South American country has become a testing ground in the race to find a vaccine.
Late stage trials are underway for vaccines under development by Oxford University/AstraZeneca, China's Sinovac Biotech, Pfizer Inc, in partnership with BioNTech and Johnson & Johnson's pharmaceutical subsidiary Janssen.
Brazil registered 432 additional coronavirus deaths over the last 24 hours and 26,979 new cases, the health ministry said on Saturday.
(With input from Reuters)

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

[size=39][size=39]Chinese partner says Pfizer COVID vaccine may reach market by December
BY 
GRADY MCGREGOR

October 27, 2020 11:39 AM GMT+5:30[/size][/size]

[size=14]
[size=14][size=14]Fosun chairman says Pfizer COVID vaccine could come as early as December 2020

Fosun Pharmaceuticals is Pfizer's Chinese partner in the development of the vaccine.



[/size][/size][/size]
Pause
[size][size][size]
Unmute
Loaded: 86.55%


 
[/size][/size][/size]
Fullscreen
[size][size][size]







COVID-19 Coronavirus Vaccine Play-button





[/size][/size][/size]
Close




  • [url=https://twitter.com/intent/tweet?text=Chinese partner says Pfizer COVID vaccine may reach market by december&url=https%3A%2F%2Ffortune.com%2F2020%2F10%2F27%2Fpfizer-vaccine-market-approval-biontech-fosun-china%2F][/url]
  • [url=https://www.linkedin.com/shareArticle/?url=https%3A%2F%2Ffortune.com%2F2020%2F10%2F27%2Fpfizer-vaccine-market-approval-biontech-fosun-china%2F&title=Chinese partner says Pfizer COVID vaccine may reach market by december&summary=Guo Guangchang%2C chairman of China%27s Fosun Group%2C is optimistic about his company%27s vaccine candidate.][/url]


[size][size]
[size=15]The experimental COVID-19 vaccine codeveloped by the U.S.’s [size=15]Pfizer, Germany’s BioNTech, and China's Fosun Pharmaceuticals may reach market as early as this December, according to the chairman of Fosun Group.
“Once the vaccine is proved to be safe and effective [after trial results are posted in November], the vaccine will be made available in the market by December [2020] or January next year,” Guo Guangchang, chair of the parent company of Fosun Pharmaceuticals, said Tuesday at the Fortune Global Forum.[/size][/size][/size][/size]

3COVID-19 Coronavirus Vaccine Empty COVID-19 Coronavirus Vaccine Wed Oct 28, 2020 3:34 am

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

COVID-19 Coronavirus Vaccine

  After long-term research and development and clinical trials, China has successfully developed a vaccine that effectively treats the new coronavirus infectious disease.
  Now the new vaccine has completed the third phase of clinical trials and approved for marketing;
  Due to the excessive global demand for vaccines, please contact us and make a order in advance.
  Quantity: ≤10000 doses/per day
COVID-19 Coronavirus Vaccine Contact-us-1

Sponsored content



Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum